Latest Financial Updates

Read latest financial news update from our blog

Evergrande shares fall nearly 90% as creditor talks postponed
Evergrande shares fall nearly 90% as creditor talks postponed

What is included in my trial? During your trial you will have complete digital access to...

Admin | Finance | 3 months ago

Delays slash solar capacity addition 53% in H1 2023
Delays slash solar capacity addition 53% in H1 2023

India's ambitious renewable energy capacity addition of 500 gigawatt by 2030 got a tempora...

Admin | Finance | 3 months ago

Brightcom shares hit 5% lower circuit for 4th day on leadership exit
Brightcom shares hit 5% lower circuit for 4th day on leadership exit

"M. Suresh Kumar Reddy, is hereby restrained from buying, selling or dealing in securities...

Admin | Finance | 3 months ago

What is behind outflows from global Gold ETFs?
What is behind outflows from global Gold ETFs?

Contrary to the prevailing trends in global Central Banks' actions, Gold backed Exchange T...

Admin | Finance | 3 months ago

Nvidia Stock Hasn’t Been This Cheap Since January, Before It Rallied 250%
Nvidia Stock Hasn’t Been This Cheap Since January, Before It Rallied 250%

If you liked the stock then, you should still like it now. Shares in Nvidia (ticker: NVDA...

Admin | Finance | 3 months ago

Vishnu Prakash R Punglia IPO Subscription: Day 3 Live Updates
Vishnu Prakash R Punglia IPO Subscription: Day 3 Live Updates

The company has design and engineering, procurement, project management, and quality manag...

Admin | Finance | 3 months ago

Bajaj Auto - Diversified Business Model With Sound Balance Sheet; Exports Recovery Impending: Axis Securities
Bajaj Auto - Diversified Business Model With Sound Balance Sheet; Exports Recovery Impending: Axis Securities

Bajaj Auto Ltd.’s focus on the 125cc+ segment is in line with the changing industry dynami...

Admin | Finance | 3 months ago

Recce Pharmaceuticals (ASX:RCE) receives green light for higher dose in rapid infusion phase I/II UTI trial
Recce Pharmaceuticals (ASX:RCE) receives green light for higher dose in rapid infusion phase I/II UTI trial

Join our daily newsletter At The Bell to receive exclusive market insights Recce Pharmace...

Admin | Finance | 3 months ago

Join Our Newsletter

join our newsletter to receive update from us